Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Receives $590M from Wellcome Trust

This article has been corrected from a previous version, which contained a currency conversion error.


NEW YORK, Dec. 23 (GenomeWeb News) - The Wellcome Trust Sanger Institute has received a five-year award totaling £340 million ($590 million) from the Wellcome Trust biomedical research charity.


The funds will be used to continue the institute's research on cancer, malaria, and diabetes, including a Cancer Genome Project that focuses on identifying the majority of mutations involved in the development of breast, lung, and kidney cancer.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.